Reni Benjamin
Stock Analyst at Citizens JMP
(0.05)
# 4,433
Out of 4,463 analysts
816
Total ratings
34.4%
Success rate
-9%
Average return
Main Sectors:
Stocks Rated by Reni Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintained: Buy | $35 → $41 | $30.24 | +35.58% | 47 | Apr 23, 2026 | |
| WHWK Whitehawk Therapeutics | Initiated Coverage: Buy | $8 | $4.30 | +86.05% | 1 | Apr 16, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $5 → $8 | $2.11 | +279.15% | 36 | Apr 14, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 → $8 | $4.21 | +90.02% | 37 | Mar 18, 2026 | |
| IMMP Immutep | Downgraded: Hold | n/a | $0.4309 | - | 2 | Mar 13, 2026 | |
| PRLD Prelude Therapeutics | Maintained: Buy | $3 → $6 | $4.91 | +22.20% | 15 | Mar 11, 2026 | |
| LYEL Lyell Immunopharma | Initiated Coverage: Buy | $34 | $12.97 | +162.14% | 1 | Mar 9, 2026 | |
| IMMX Immix Biopharma | Initiated Coverage: Buy | $23 | $9.83 | +133.98% | 1 | Mar 9, 2026 | |
| IOVA Iovance Biotherapeutics | Upgraded: Buy | $5 | $3.97 | +25.94% | 49 | Feb 25, 2026 | |
| BCAX Bicara Therapeutics | Initiated Coverage: Buy | $31 | $28.91 | +7.23% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.353 | - | 12 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $25.72 | +24.42% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.18 | +358.72% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $348 → $396 | $290.74 | +36.20% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $8 | $3.56 | +124.72% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.62 | - | 28 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $10.78 | +122.63% | 41 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $113.81 | - | 105 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.09 | - | 23 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $14.38 | +178.16% | 8 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.69 | - | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $94.94 | n/a | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $28.34 | n/a | 27 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.13 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.95 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0006 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.10 | n/a | 20 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $0.04 | n/a | 19 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.62 | n/a | 24 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $57.82 | n/a | 1 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $5 | $1.30 | n/a | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $57 | $37.94 | n/a | 14 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 → $94 | $13.09 | n/a | 12 | Feb 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $1.21 | n/a | 4 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 | $2.16 | n/a | 25 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $3.60 | n/a | 9 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $10 | $8.61 | n/a | 17 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $13 | $0.6441 | n/a | 16 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $53.52 | n/a | 25 | Aug 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.06 | n/a | 8 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.02 | n/a | 21 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.20 | n/a | 14 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.27 | n/a | 10 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0418 | n/a | 7 | Jun 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0013 | n/a | 1 | May 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.88 | n/a | 7 | May 21, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | May 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $4.63 | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $1.00 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $23.07 | n/a | 7 | Mar 19, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.09 | n/a | 4 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.41 | n/a | 6 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.0001 | n/a | 6 | Dec 11, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.97 | n/a | 3 | Oct 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $34.67 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 | $18.20 | n/a | 1 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.27 | n/a | 2 | Oct 12, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.24 | n/a | 2 | May 10, 2010 |
Sutro Biopharma
Apr 23, 2026
Maintained: Buy
Price Target: $35 → $41
Current: $30.24
Upside: +35.58%
Whitehawk Therapeutics
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $4.30
Upside: +86.05%
Allogene Therapeutics
Apr 14, 2026
Maintained: Buy
Price Target: $5 → $8
Current: $2.11
Upside: +279.15%
Bicycle Therapeutics
Mar 18, 2026
Maintained: Buy
Price Target: $12 → $8
Current: $4.21
Upside: +90.02%
Immutep
Mar 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4309
Upside: -
Prelude Therapeutics
Mar 11, 2026
Maintained: Buy
Price Target: $3 → $6
Current: $4.91
Upside: +22.20%
Lyell Immunopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $12.97
Upside: +162.14%
Immix Biopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $9.83
Upside: +133.98%
Iovance Biotherapeutics
Feb 25, 2026
Upgraded: Buy
Price Target: $5
Current: $3.97
Upside: +25.94%
Bicara Therapeutics
Jan 29, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $28.91
Upside: +7.23%
Dec 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.353
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $25.72
Upside: +24.42%
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $2.18
Upside: +358.72%
Nov 7, 2025
Maintained: Buy
Price Target: $348 → $396
Current: $290.74
Upside: +36.20%
Oct 30, 2025
Maintained: Buy
Price Target: $5 → $8
Current: $3.56
Upside: +124.72%
Oct 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.62
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: $24
Current: $10.78
Upside: +122.63%
Sep 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $113.81
Upside: -
Sep 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.09
Upside: -
Sep 8, 2025
Reiterated: Buy
Price Target: $40
Current: $14.38
Upside: +178.16%
Aug 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $7.69
Upside: -
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $94.94
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: $2
Current: $28.34
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $2.13
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $1.95
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0006
Upside: n/a
May 10, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.10
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $16 → $6
Current: $0.04
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: n/a
Current: $4.62
Upside: n/a
Apr 9, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $57.82
Upside: n/a
Mar 18, 2019
Maintained: Buy
Price Target: $6 → $5
Current: $1.30
Upside: n/a
Mar 1, 2019
Maintained: Buy
Price Target: $73 → $57
Current: $37.94
Upside: n/a
Feb 5, 2019
Upgraded: Buy
Price Target: $96 → $94
Current: $13.09
Upside: n/a
Dec 13, 2018
Maintained: Buy
Price Target: $21
Current: $1.21
Upside: n/a
Nov 15, 2018
Upgraded: Buy
Price Target: $5
Current: $2.16
Upside: n/a
Nov 14, 2018
Upgraded: Buy
Price Target: n/a
Current: $3.60
Upside: n/a
Oct 12, 2018
Maintained: Buy
Price Target: $11 → $10
Current: $8.61
Upside: n/a
Aug 28, 2018
Maintained: Buy
Price Target: $13 → $13
Current: $0.6441
Upside: n/a
Aug 14, 2018
Maintained: Buy
Price Target: $22
Current: $53.52
Upside: n/a
Aug 10, 2018
Maintained: Hold
Price Target: n/a
Current: $1.06
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $3.02
Upside: n/a
Aug 7, 2018
Maintained: Hold
Price Target: n/a
Current: $9.20
Upside: n/a
Dec 18, 2017
Rated: Hold
Price Target: n/a
Current: $13.27
Upside: n/a
Jun 4, 2015
Reiterated: Buy
Price Target: $6
Current: $0.0418
Upside: n/a
May 26, 2015
Initiated Coverage: Buy
Price Target: $13
Current: $0.0013
Upside: n/a
May 21, 2015
Maintained: Buy
Price Target: $8
Current: $1.88
Upside: n/a
May 15, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $7 → $3
Current: $4.63
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $9 → $5
Current: $1.00
Upside: n/a
Mar 19, 2015
Reiterated: Buy
Price Target: $8 → $12
Current: $23.07
Upside: n/a
Feb 18, 2015
Reiterated: Buy
Price Target: $4
Current: $2.09
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $6
Current: $3.41
Upside: n/a
Dec 11, 2014
Maintained: Buy
Price Target: $40
Current: $0.0001
Upside: n/a
Oct 13, 2014
Maintained: Hold
Price Target: n/a
Current: $1.97
Upside: n/a
May 5, 2014
Initiated Coverage: Buy
Price Target: $17
Current: $34.67
Upside: n/a
Jul 24, 2013
Downgraded: Hold
Price Target: $39
Current: $18.20
Upside: n/a
Oct 12, 2010
Reiterated: Buy
Price Target: $9
Current: $1.27
Upside: n/a
May 10, 2010
Reiterated: Buy
Price Target: n/a
Current: $3.24
Upside: n/a